Menu

绥美凯能吃多久?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

On January 20, 2018, ViiV, a joint venture of GlaxoSmithKline (hereinafter referred to as GSK), the first complete antiviral treatment drug with dolutegravir (also known as DTG in English) as the core - dolutegravir tablets was officially launched in China. This is also the first complete single-tablet compound treatment plan in the field of HIV treatment in China.

How long can Suimeikai be taken?

Generally speaking, as long as the patient has not developed resistance to Suimeike (Dolutea Paramid Tablets), he can continue to take it. Dolutegravir tablets are composed of three ingredients: DTG (DTG) + abacavir (ABC) + lamivudine (3TC). It is a compound treatment agent of integrase inhibitors and nucleoside drugs. Since the advent of the first anti-HIV treatment agent zidovudine (AZT) in 1987, which has brought hope to AIDS patients, more and more drugs have continued to appear, including efavirenz (EVF), Kaletra, tenofovir, and Ascent, until the newly released Tevicay in recent years. Anti-AIDS drugs have experienced the nucleoside With the development of different types of inhibitors, non-nucleoside inhibitors, protease inhibitors and integrase inhibitors in different periods, there are more and more types of drugs, the therapeutic effects are getting better and better, and the side effects are getting less and less. At present, the world has basically entered the era of integrase inhibitor drugs, and the optimization of multi-drug combination programs is constantly innovating. In 2016, GSK announced the launch of the integrase DTG (Tevicai) in China. This therapeutic agent has the advantages of small drug dosage, low resistance to drug resistance, and low probability of drug side effects. This time, doptabalamid tablets are based on DTG, an integrase inhibitor, as the core drug, coupled with a treatment plan of two backbone drugs, abacavir and lamivudine, and made into a single tablet treatment for promotion, making the core drug a great progress in HAART treatment.

The dosage is one tablet each time, once a day. There is no specific limit on the time of taking. It can be taken at a fixed time every day. When the weight is less than 40kg, this drug generally cannot be used. This drug is a fixed-dose preparation and the dosage cannot be reduced. However, this dosage of doptabalamid tablets cannot be used on patients who need to adjust the dosage.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。